Literature DB >> 31916377

Standards for the development and methodology of the 2019 International Working Group on the Diabetic Foot guidelines.

Sicco A Bus1, Jaap J Van Netten1,2,3, Robert J Hinchliffe4, Jan Apelqvist5, Benjamin A Lipsky6, Nicolaas C Schaper7.   

Abstract

Diabetic foot disease is a source of major patient suffering and societal costs. Investing in evidence-based international guidelines on diabetic foot disease is likely among the most cost-effective forms of health care expenditure, provided the guidelines are outcome focused, evidence based, and properly implemented. The International Working Group on the Diabetic Foot (IWGDF) has published and updated international guidelines since 1999. The 2019 updates are based on formulating relevant clinical questions and outcomes, rigorous systematic reviews of the literature, and recommendations that are specific, and unambiguous along with their transparent rationale, all using the Grading of Recommendations Assessment Development and Evaluation (GRADE) framework. We herein describe the development of the 2019 IWGDF guidelines on the prevention and management of diabetic foot disease, which consists of six chapters, each prepared by a separate working group of international experts. These documents provide guidelines related to diabetic foot disease on prevention; offloading; peripheral artery disease; infection; wound healing interventions; and classification of diabetic foot ulcers. Based on these six chapters, the IWGDF Editorial Board also produced a set of practical guidelines. Each guideline underwent extensive review by the members of the IWGDF Editorial Board as well as independent international experts in each field. We believe that adoption and implementation of the 2019 IWGDF guidelines by health care providers, public health agencies, and policymakers will result in improved prevention and management of diabetic foot disease and a subsequent worldwide reduction in the patient and societal burden this disease causes.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  IWGDF; diabetic foot; diabetic foot disease; foot ulcer; guidance; guidelines; implementation

Mesh:

Year:  2020        PMID: 31916377     DOI: 10.1002/dmrr.3267

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  7 in total

Review 1.  Macrophages as a therapeutic target to promote diabetic wound healing.

Authors:  Maryam Sharifiaghdam; Elnaz Shaabani; Reza Faridi-Majidi; Stefaan C De Smedt; Kevin Braeckmans; Juan C Fraire
Journal:  Mol Ther       Date:  2022-08-02       Impact factor: 12.910

2.  Australian guideline on management of diabetes-related foot infection: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Robert J Commons; James Charles; Jane Cheney; Sarah A Lynar; Matthew Malone; Edward Raby
Journal:  J Foot Ankle Res       Date:  2022-06-09       Impact factor: 3.050

3.  Differences in initial versus recurrent diabetic foot ulcers at a specialized tertiary diabetic foot care center in China.

Authors:  Yuxia Cheng; Ping Zu; Jie Zhao; Lintao Shi; Hongyan Shi; Mei Zhang; Aihong Wang
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

4.  Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial.

Authors:  Yu-Yao Huang; Ching-Wen Lin; Nai-Chen Cheng; Shawn M Cazzell; Hsin-Han Chen; Kuo-Feng Huang; Kwang-Yi Tung; Hsuan-Li Huang; Pao-Yuan Lin; Cherng-Kang Perng; Bimin Shi; Chang Liu; Yujin Ma; Yemin Cao; Yanbing Li; Yaoming Xue; Li Yan; Qiu Li; Guang Ning; Shun-Cheng Chang
Journal:  JAMA Netw Open       Date:  2021-09-01

5.  Guidelines development protocol and findings: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Peter A Lazzarini; Anita Raspovic; Jenny Prentice; Robert J Commons; Robert A Fitridge; James Charles; Jane Cheney; Nytasha Purcell; Stephen M Twigg
Journal:  J Foot Ankle Res       Date:  2022-04-19       Impact factor: 3.050

6.  Diabetic foot disease: "The Times They are A Changin' ".

Authors:  Sicco A Bus; Jaap J van Netten; Matilde Monteiro-Soares; Benjamin A Lipsky; Nicolaas C Schaper
Journal:  Diabetes Metab Res Rev       Date:  2020-03       Impact factor: 4.876

7.  Fast-track pathway for diabetic foot ulceration during COVID-19 crisis: A document from International Diabetic Foot Care Group and D-Foot International.

Authors:  Marco Meloni; Benjamin Bouillet; Raju Ahluwalia; Claas Lüdemann; Juan Pedro Sánchez-Ríos; Elisabetta Iacopi; José Luis Lazaro-Martinez
Journal:  Diabetes Metab Res Rev       Date:  2020-08-25       Impact factor: 8.128

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.